Titre : Intégrines

Intégrines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developmental Disabilities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Intégrines : Questions médicales les plus fréquentes", "headline": "Intégrines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Intégrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-09", "dateModified": "2025-05-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Intégrines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Récepteurs immunologiques", "url": "https://questionsmedicales.fr/mesh/D011971", "about": { "@type": "MedicalCondition", "name": "Récepteurs immunologiques", "code": { "@type": "MedicalCode", "code": "D011971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Intégrines alpha", "alternateName": "Integrin alpha Chains", "url": "https://questionsmedicales.fr/mesh/D039001", "about": { "@type": "MedicalCondition", "name": "Intégrines alpha", "code": { "@type": "MedicalCode", "code": "D039001", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Intégrine alpha1", "alternateName": "Integrin alpha1", "url": "https://questionsmedicales.fr/mesh/D039423", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha1", "code": { "@type": "MedicalCode", "code": "D039423", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.300" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alpha2", "alternateName": "Integrin alpha2", "url": "https://questionsmedicales.fr/mesh/D039421", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha2", "code": { "@type": "MedicalCode", "code": "D039421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.350" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alpha3", "alternateName": "Integrin alpha3", "url": "https://questionsmedicales.fr/mesh/D039422", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha3", "code": { "@type": "MedicalCode", "code": "D039422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.400" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alpha4", "alternateName": "Integrin alpha4", "url": "https://questionsmedicales.fr/mesh/D039441", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha4", "code": { "@type": "MedicalCode", "code": "D039441", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.450" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alpha5", "alternateName": "Integrin alpha5", "url": "https://questionsmedicales.fr/mesh/D039482", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha5", "code": { "@type": "MedicalCode", "code": "D039482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.500" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alpha6", "alternateName": "Integrin alpha6", "url": "https://questionsmedicales.fr/mesh/D039503", "about": { "@type": "MedicalCondition", "name": "Intégrine alpha6", "code": { "@type": "MedicalCode", "code": "D039503", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.550" } } }, { "@type": "MedicalWebPage", "name": "Intégrine alphaV", "alternateName": "Integrin alphaV", "url": "https://questionsmedicales.fr/mesh/D039564", "about": { "@type": "MedicalCondition", "name": "Intégrine alphaV", "code": { "@type": "MedicalCode", "code": "D039564", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.900" } } }, { "@type": "MedicalWebPage", "name": "Glycoprotéine-IIb de membrane plaquettaire", "alternateName": "Platelet Membrane Glycoprotein IIb", "url": "https://questionsmedicales.fr/mesh/D040201", "about": { "@type": "MedicalCondition", "name": "Glycoprotéine-IIb de membrane plaquettaire", "code": { "@type": "MedicalCode", "code": "D040201", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.100.950" } } } ] }, { "@type": "MedicalWebPage", "name": "Chaines bêta des intégrines", "alternateName": "Integrin beta Chains", "url": "https://questionsmedicales.fr/mesh/D039641", "about": { "@type": "MedicalCondition", "name": "Chaines bêta des intégrines", "code": { "@type": "MedicalCode", "code": "D039641", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antigènes CD29", "alternateName": "Integrin beta1", "url": "https://questionsmedicales.fr/mesh/D019012", "about": { "@type": "MedicalCondition", "name": "Antigènes CD29", "code": { "@type": "MedicalCode", "code": "D019012", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.200.500" } } }, { "@type": "MedicalWebPage", "name": "Intégrine bêta3", "alternateName": "Integrin beta3", "url": "https://questionsmedicales.fr/mesh/D039661", "about": { "@type": "MedicalCondition", "name": "Intégrine bêta3", "code": { "@type": "MedicalCode", "code": "D039661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.200.750" } } }, { "@type": "MedicalWebPage", "name": "Intégrine bêta4", "alternateName": "Integrin beta4", "url": "https://questionsmedicales.fr/mesh/D039663", "about": { "@type": "MedicalCondition", "name": "Intégrine bêta4", "code": { "@type": "MedicalCode", "code": "D039663", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.200.800" } } } ] }, { "@type": "MedicalWebPage", "name": "Récepteur cytoadhésine", "alternateName": "Receptors, Cytoadhesin", "url": "https://questionsmedicales.fr/mesh/D016024", "about": { "@type": "MedicalCondition", "name": "Récepteur cytoadhésine", "code": { "@type": "MedicalCode", "code": "D016024", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.460" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Récepteur vitronectine", "alternateName": "Receptors, Vitronectin", "url": "https://questionsmedicales.fr/mesh/D019030", "about": { "@type": "MedicalCondition", "name": "Récepteur vitronectine", "code": { "@type": "MedicalCode", "code": "D019030", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.460.870" } } } ] }, { "@type": "MedicalWebPage", "name": "Récepteur du fibrinogène", "alternateName": "Receptors, Fibrinogen", "url": "https://questionsmedicales.fr/mesh/D039341", "about": { "@type": "MedicalCondition", "name": "Récepteur du fibrinogène", "code": { "@type": "MedicalCode", "code": "D039341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.495" } } }, { "@type": "MedicalWebPage", "name": "Récepteur fibronectine", "alternateName": "Receptors, Fibronectin", "url": "https://questionsmedicales.fr/mesh/D017469", "about": { "@type": "MedicalCondition", "name": "Récepteur fibronectine", "code": { "@type": "MedicalCode", "code": "D017469", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.530" } } }, { "@type": "MedicalWebPage", "name": "Récepteur adhésion leucocytaire", "alternateName": "Receptors, Leukocyte-Adhesion", "url": "https://questionsmedicales.fr/mesh/D016028", "about": { "@type": "MedicalCondition", "name": "Récepteur adhésion leucocytaire", "code": { "@type": "MedicalCode", "code": "D016028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.600" } } }, { "@type": "MedicalWebPage", "name": "Récepteur VLA", "alternateName": "Receptors, Very Late Antigen", "url": "https://questionsmedicales.fr/mesh/D016029", "about": { "@type": "MedicalCondition", "name": "Récepteur VLA", "code": { "@type": "MedicalCode", "code": "D016029", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.750.705.408.850" } } } ], "about": { "@type": "MedicalCondition", "name": "Intégrines", "alternateName": "Integrins", "code": { "@type": "MedicalCode", "code": "D016023", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Johanna Ivaska", "url": "https://questionsmedicales.fr/author/Johanna%20Ivaska", "affiliation": { "@type": "Organization", "name": "Turku Bioscience Center, University of Turku and Åbo Akademi University, FIN-20520 Turku, Finland; Department of Biochemistry, University of Turku, FIN-20520 Turku, Finland. Electronic address: joivaska@utu.fi." } }, { "@type": "Person", "name": "Jia Liu", "url": "https://questionsmedicales.fr/author/Jia%20Liu", "affiliation": { "@type": "Organization", "name": "Shenzhen Jiake Biotechnology, Shenzhen, China." } }, { "@type": "Person", "name": "Michael Bachmann", "url": "https://questionsmedicales.fr/author/Michael%20Bachmann", "affiliation": { "@type": "Organization", "name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland." } }, { "@type": "Person", "name": "Vesa P Hytönen", "url": "https://questionsmedicales.fr/author/Vesa%20P%20Hyt%C3%B6nen", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, FI-33520 Tampere, Finland." } }, { "@type": "Person", "name": "Bernhard Wehrle-Haller", "url": "https://questionsmedicales.fr/author/Bernhard%20Wehrle-Haller", "affiliation": { "@type": "Organization", "name": "Department of Cell Physiology and Metabolism, University of Geneva, Centre Médical Universitaire, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland bernhard.wehrle-haller@unige.ch." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Perinatal and Postpartum Health Among People With Intellectual and Developmental Disabilities.", "datePublished": "2024-08-01", "url": "https://questionsmedicales.fr/article/39145975", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2024.28067" } }, { "@type": "ScholarlyArticle", "name": "Elevated risk for developmental disabilities in children with congenital heart defects.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37681320", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/bdr2.2246" } }, { "@type": "ScholarlyArticle", "name": "Parental Perceptions of Family-Centred Supports for Children with Developmental Disabilities.", "datePublished": "2023-02-27", "url": "https://questionsmedicales.fr/article/36901214", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20054205" } }, { "@type": "ScholarlyArticle", "name": "The Efficacy of Parent Training Interventions with Parents of Children with Developmental Disabilities.", "datePublished": "2022-08-05", "url": "https://questionsmedicales.fr/article/35955038", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph19159685" } }, { "@type": "ScholarlyArticle", "name": "Challenges of single parents raising children with intellectual and developmental disabilities.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36896654", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jar.13093" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Récepteurs de surface cellulaire", "item": "https://questionsmedicales.fr/mesh/D011956" }, { "@type": "ListItem", "position": 6, "name": "Récepteurs immunologiques", "item": "https://questionsmedicales.fr/mesh/D011971" }, { "@type": "ListItem", "position": 7, "name": "Intégrines", "item": "https://questionsmedicales.fr/mesh/D016023" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Intégrines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Intégrines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Intégrines", "description": "Comment diagnostiquer une dysfonction des intégrines ?\nQuels examens sont utilisés pour évaluer les intégrines ?\nLes biopsies sont-elles utiles pour les intégrines ?\nPeut-on détecter les intégrines par imagerie ?\nQuels marqueurs sont associés aux intégrines ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Intégrines", "description": "Quels symptômes indiquent une anomalie des intégrines ?\nLes troubles de la coagulation sont-ils liés aux intégrines ?\nComment les intégrines affectent-elles la cicatrisation ?\nLes douleurs articulaires peuvent-elles être liées aux intégrines ?\nY a-t-il des symptômes cutanés associés aux intégrines ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Intégrines", "description": "Peut-on prévenir les troubles liés aux intégrines ?\nLes vaccinations influencent-elles les intégrines ?\nL'exercice physique affecte-t-il les intégrines ?\nLe stress a-t-il un impact sur les intégrines ?\nLes habitudes alimentaires influencent-elles les intégrines ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Intégrines", "description": "Quels traitements ciblent les intégrines ?\nLes médicaments anti-inflammatoires aident-ils les intégrines ?\nLa thérapie génique peut-elle corriger les anomalies des intégrines ?\nLes greffes d'organes sont-elles affectées par les intégrines ?\nComment les intégrines sont-elles ciblées dans le cancer ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Intégrines", "description": "Quelles complications peuvent survenir avec des anomalies des intégrines ?\nLes anomalies des intégrines peuvent-elles causer des cancers ?\nComment les intégrines affectent-elles la santé cardiovasculaire ?\nLes complications cutanées sont-elles fréquentes avec les intégrines ?\nLes troubles neurologiques peuvent-ils être liés aux intégrines ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Intégrines", "description": "Quels facteurs augmentent le risque de troubles des intégrines ?\nL'âge influence-t-il la fonction des intégrines ?\nLe tabagisme affecte-t-il les intégrines ?\nLe diabète influence-t-il les intégrines ?\nLe stress oxydatif affecte-t-il les intégrines ?", "url": "https://questionsmedicales.fr/mesh/D016023?mesh_terms=Developmental+Disabilities&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des intégrines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de sang peuvent aider à diagnostiquer les anomalies des intégrines." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les intégrines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunofluorescence et la cytométrie en flux sont couramment utilisés pour évaluer les intégrines." } }, { "@type": "Question", "name": "Les biopsies sont-elles utiles pour les intégrines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les biopsies peuvent révéler des anomalies d'expression des intégrines dans les tissus." } }, { "@type": "Question", "name": "Peut-on détecter les intégrines par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Certaines techniques d'imagerie moléculaire peuvent visualiser l'expression des intégrines." } }, { "@type": "Question", "name": "Quels marqueurs sont associés aux intégrines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme CD29 et CD49 peuvent être utilisés pour identifier les intégrines." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie des intégrines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des problèmes d'adhésion cellulaire peuvent entraîner des inflammations et des infections récurrentes." } }, { "@type": "Question", "name": "Les troubles de la coagulation sont-ils liés aux intégrines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies des intégrines peuvent provoquer des troubles de la coagulation sanguine." } }, { "@type": "Question", "name": "Comment les intégrines affectent-elles la cicatrisation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les intégrines sont essentielles pour la migration cellulaire et la formation de nouveaux tissus lors de la cicatrisation." } }, { "@type": "Question", "name": "Les douleurs articulaires peuvent-elles être liées aux intégrines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements des intégrines peuvent contribuer à des douleurs articulaires et à l'arthrite." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés aux intégrines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies des intégrines peuvent entraîner des maladies cutanées comme l'épidermolyse bulleuse." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux intégrines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles liés aux intégrines." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles les intégrines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent moduler l'expression des intégrines, influençant la réponse immunitaire." } }, { "@type": "Question", "name": "L'exercice physique affecte-t-il les intégrines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la fonction des intégrines et la santé cellulaire." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les intégrines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut altérer l'expression des intégrines, affectant la santé immunitaire." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les intégrines ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut soutenir la fonction des intégrines et la santé cellulaire." } }, { "@type": "Question", "name": "Quels traitements ciblent les intégrines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies biologiques, comme les inhibiteurs d'intégrines, sont utilisées pour traiter certaines maladies auto-immunes." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires aident-ils les intégrines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anti-inflammatoires peuvent réduire l'inflammation liée aux dysfonctionnements des intégrines." } }, { "@type": "Question", "name": "La thérapie génique peut-elle corriger les anomalies des intégrines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est une approche prometteuse pour corriger certaines anomalies des intégrines." } }, { "@type": "Question", "name": "Les greffes d'organes sont-elles affectées par les intégrines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les intégrines jouent un rôle clé dans l'acceptation ou le rejet des greffes d'organes." } }, { "@type": "Question", "name": "Comment les intégrines sont-elles ciblées dans le cancer ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements ciblant les intégrines peuvent inhiber la métastase et la progression tumorale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des anomalies des intégrines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des infections récurrentes, des troubles de la coagulation et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les anomalies des intégrines peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans l'expression des intégrines sont associées à une augmentation du risque de cancer." } }, { "@type": "Question", "name": "Comment les intégrines affectent-elles la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des dysfonctionnements des intégrines peuvent contribuer à des maladies cardiovasculaires et à l'athérosclérose." } }, { "@type": "Question", "name": "Les complications cutanées sont-elles fréquentes avec les intégrines ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies des intégrines peuvent entraîner des maladies cutanées graves comme l'épidermolyse." } }, { "@type": "Question", "name": "Les troubles neurologiques peuvent-ils être liés aux intégrines ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les anomalies des intégrines et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles des intégrines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs génétiques, des infections chroniques et des maladies auto-immunes augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il la fonction des intégrines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut altérer l'expression et la fonction des intégrines dans le corps." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il les intégrines ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut perturber l'expression des intégrines et affecter la santé cellulaire." } }, { "@type": "Question", "name": "Le diabète influence-t-il les intégrines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut altérer la fonction des intégrines, augmentant le risque de complications." } }, { "@type": "Question", "name": "Le stress oxydatif affecte-t-il les intégrines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut endommager les intégrines et perturber leur fonction normale." } } ] } ] }

Sous-catégories

19 au total
└─

Intégrines alpha

Integrin alpha Chains D039001 - D12.776.543.750.705.408.100
└─

Chaines bêta des intégrines

Integrin beta Chains D039641 - D12.776.543.750.705.408.200
└─

Récepteur cytoadhésine

Receptors, Cytoadhesin D016024 - D12.776.543.750.705.408.460
└─

Récepteur du fibrinogène

Receptors, Fibrinogen D039341 - D12.776.543.750.705.408.495
└─

Récepteur fibronectine

Receptors, Fibronectin D017469 - D12.776.543.750.705.408.530
└─

Récepteur adhésion leucocytaire

Receptors, Leukocyte-Adhesion D016028 - D12.776.543.750.705.408.600
└─

Récepteur VLA

Receptors, Very Late Antigen D016029 - D12.776.543.750.705.408.850
└─└─

Intégrine alpha1

Integrin alpha1 D039423 - D12.776.543.750.705.408.100.300
└─└─

Intégrine alpha2

Integrin alpha2 D039421 - D12.776.543.750.705.408.100.350
└─└─

Intégrine alpha3

Integrin alpha3 D039422 - D12.776.543.750.705.408.100.400
└─└─

Intégrine alpha4

Integrin alpha4 D039441 - D12.776.543.750.705.408.100.450
└─└─

Intégrine alpha5

Integrin alpha5 D039482 - D12.776.543.750.705.408.100.500
└─└─

Intégrine alpha6

Integrin alpha6 D039503 - D12.776.543.750.705.408.100.550
└─└─

Intégrine alphaV

Integrin alphaV D039564 - D12.776.543.750.705.408.100.900
└─└─

Glycoprotéine-IIb de membrane plaquettaire

Platelet Membrane Glycoprotein IIb D040201 - D12.776.543.750.705.408.100.950
└─└─

Antigènes CD29

Integrin beta1 D019012 - D12.776.543.750.705.408.200.500
└─└─

Intégrine bêta3

Integrin beta3 D039661 - D12.776.543.750.705.408.200.750
└─└─

Intégrine bêta4

Integrin beta4 D039663 - D12.776.543.750.705.408.200.800
└─└─

Récepteur vitronectine

Receptors, Vitronectin D019030 - D12.776.543.750.705.408.460.870

Sources (10000 au total)

Perinatal and Postpartum Health Among People With Intellectual and Developmental Disabilities.

Small, geographically limited studies report that people with intellectual and developmental disabilities (IDD) have increased risk for serious pregnancy-related and birth-related challenges, includin... To identify perinatal and postpartum outcomes among a national, longitudinal sample of people with IDD enrolled in public health insurance, compare subgroups of people with IDD, and compare outcomes a... This retrospective cohort study used national Medicaid claims from January 1, 2008, to December 31, 2019, for 55 440 birthing people with IDD and a random sample of 438 557 birthing people without IDD... People who had a documented birth in Medicaid during the study years.... Perinatal outcomes were compared across groups using univariate and multivariate logistic regression. The probability of postpartum anxiety and depression was estimated using Kaplan-Meier and Cox prop... The study sample included 55 440 birthing people with IDD (including 41 854 with intellectual disabilities [ID] and 13 586 with autism; mean [SD] age at first delivery, 24.9 [6.7] years) and a random ... In this retrospective cohort study, people with IDD had a younger mean age at first delivery, had lower prevalence of live births, and had poor obstetric, mental health, and medical outcomes compared ...

Elevated risk for developmental disabilities in children with congenital heart defects.

This study examined risk for developmental disabilities in preschool-aged children with a congenital heart defect (CHD) at the population level.... Statewide birth, birth defects, and preschool developmental disability records were integrated. The final sample included 1,966,585 children (51.0% male). Children were grouped by type(s) of CHD: crit... Children with a CHD (any type) were at increased risk for developmental disability (any type) (RR 2.08, 95% CI 2.03-2.14, P < .001). Children in the critical CHD, noncritical CHD, and atrial septal de... Increased risk for developmental disabilities was identified for children with less severe CHDs as well as for children with more severe (critical) CHDs. All children with CHDs should be closely monit...

Challenges of single parents raising children with intellectual and developmental disabilities.

Single-parent families with children with disabilities need greater attention given the notable increase in their number and their additional difficulties. Single parents in East Asian countries, espe... The study used a mixed methods design; we administered a risk assessment survey to 354 families of children with intellectual and developmental disabilities and conducted in-depth interviews with eigh... Compared to two-parent families, single-parent families faced greater risks with respect to family relationships, economic status and legal rights. In the interviews, single parents reported a range o... These findings offer implications for future policy and practices concerning single parents in South Korea....

Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.

To compare contraceptive provision to women with and without intellectual and developmental disabilities enrolled in North Carolina Medicaid.... Our retrospective cohort study used 2019 North Carolina Medicaid claims to identify women aged 15-44 years with and without intellectual and developmental disabilities at risk for pregnancy who were c... Among 9,508 women with intellectual and developmental disabilities and 299,978 without, a significantly smaller proportion with intellectual and developmental disabilities received most or moderately ... These findings suggest disparities in contraceptive provision and potential differences in clinical indication by intellectual and developmental disability status. Future studies should investigate re...

Language development trajectories in young children with developmental disabilities in Taiwan.

Language development is critical to various outcomes in young children with developmental disabilities (DD), including autism spectrum disorder (ASD) and non-ASD delays. However, language development ... To investigate the language development trajectories of young children with DD in Taiwan. We investigated the relationship between trajectory class assignment and diagnostic outcomes (ASD or non-ASD d... The participants were 101 young children with DD (mean age: 21.88 months; follow-up: 1.5 and 3 years after enrollment). Growth mixture modeling analyses were conducted to receptive language developmen... Three RLDQ trajectories were identified, namely age expected, delayed catch-up, and delayed, and two ELDQ trajectories were identified, namely delayed improve and delayed. Trajectory class assignment ... Language development in young children with DD in Taiwan is heterogeneous. Delayed receptive and expressive language development trajectories relate to later ASD diagnoses....

Telerehabilitation for Children and Youth with Developmental Disabilities and Their Families: A Systematic Review.

To determine the level of evidence for the effectiveness of telerehabilitation against comparison interventions in improving child- and parent-related outcomes in children and youth with developmental... A systematic approach, comprised of a comprehensive search; transparent study selection, data extraction, quality assessment by independent reviewers; and synthesis of sufficiently similar data (per d... Fifty-five studies (29 randomized trials) were included across six diagnostic groups and ten health professions. Common telerehabilitation targets varied across diagnostic groups and included motor fu... There is sufficient evidence suggesting that telerehabilitation is a promising alternative when face-to-face care is limited. It is comparable to usual care and is more effective than no treatment. Bl...

Psychiatric diagnostic dilemmas among people with intellectual and developmental disabilities.

Research regarding the accuracy of co-morbid psychiatric diagnoses in individuals with intellectual and developmental disabilities (IDD) is sparse. Yet correct diagnostic assignment is vital so that e... A retrospective review of de-identified data from multidisciplinary specialty team assessments completed for 50 individuals with ID (IntellectualDisability) with and without ASD and unresolved behavio... The most common chief complaints upon referral were aggression to others and self-injurious behaviour. Individuals were taking a median of six medications (interquartile range: 5 to 7); 80% were takin... Individuals in the current study had serious psychiatric and behavioural problems despite psychiatric care in their communities. The majority of psychiatric diagnoses provided upon referral were not s...